实例探究.
我们的案例数据库覆盖了全球物联网生态系统中的 18,927 家解决方案供应商。
您可以通过筛选条件进行快速浏览。
-
(4)
- (4)
- (2)
- (1)
-
(2)
- (1)
- (1)
-
(1)
- (1)
-
(1)
- (1)
- (3)
- (1)
- (1)
- (4)
- (3)
- (1)
- (3)
- (2)
- (1)
- (1)
- (1)
- 查看全部 7 用例
- (4)
- (3)
- (1)
- (4)
Selected Filters
4 实例探究
全球 50 大消费品 (CPG)
Savi Technology
一家全球 50 强消费品 (CPG) 公司平均每月运送 25,000 辆北美卡车。由于没有实时监控在途库存的系统,运营团队成员不知道实时中断,使他们无法避免或减轻客户延迟或未交付的情况。一个新的战略交叉对接网络无法实现高效目标,因为入站预计到达时间 (ETA) 不准确——减少了可以交叉对接的货物数量。运输管理系统 (TMS) 和企业资源规划 (ERP) 系统没有收到实时信息,也很少收到货运计划更新。
|
Improve Just-in-Time Production with Real-Time Tracking of Goods
Savi Technology
A leading global CPG company faced challenges in their European sector due to on-time delivery complications for shipments that crossed multiple land and sea borders. The company needed to plan heavily around the estimated time of arrival (ETA) of raw goods at their production facilities, which were limited on space. Receiving goods just-in-time for production was essential to minimize stock levels and avoid delays in production schedules. Therefore, they required a solution that would provide greater visibility and accurate ETAs to ensure timely receipt of materials.
|
Radically Improve Operations with Estimated Time of Arrival
Savi Technology
A large Consumer Packaged Goods (CPG) company needed end-to-end supply chain visibility with an emphasis on timeliness. Their current visibility was limited to the day of delivery and lacked precise and accurate time of arrivals, causing numerous operational inefficiencies. The company had previously invested in traditional solutions, such as warehouse and transportation management systems, and spent millions of dollars working with several consulting and technology providers who didn’t deliver the results or solutions they needed. Ultimately, they were left relying on drivers to provide estimated time of arrivals (ETA) and employees to manually update statuses.
|
Transform and Improve Your Operations with True Visibility
Savi Technology
One of the world’s leading biotechnology companies, focusing on developing therapies for multiple sclerosis, hemophilia, and other autoimmune disorders, needed true end-to-end supply chain visibility. This pharmaceutical company ships their therapies around the world, often through high-risk areas to reach their patients. With individual shipments worth 20-30 million dollars, supply chain performance and visibility are of utmost importance. Despite this, they did not know the current routes taken between origin and destination sites and, consequently, they were unaware of specific areas of risk or loss. As a result, this company needed better insight into the actual performance of their supply chain to optimize route performance and identify areas of risk for securing their goods from theft.
|